about
Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxinMining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cellsQuantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patientsAdaptive responses to dasatinib-treated lung squamous cell cancer cells harboring DDR2 mutations.Co-evolution of somatic variation in primary and metastatic colorectal cancer may expand biopsy indications in the molecular eraAn improved understanding of cancer genomics through massively parallel sequencing.Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma.Myoepithelial carcinoma with RB1 mutation: remarkable chemosensitivity to carcinoma of unknown origin therapy.Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing.Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutationRegulation of S phase.Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma.Massively parallel sequencing, aCGH, and RNA-Seq technologies provide a comprehensive molecular diagnosis of Fanconi anemia.Use of HLA peptidomics and whole exome sequencing to identify human immunogenic neo-antigens.A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC.JAK1 truncating mutations in gynecologic cancer define new role of cancer-associated protein tyrosine kinase aberrationsInactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation.Non-malignant respiratory epithelial cells preferentially proliferate from resected non-small cell lung cancer specimens cultured under conditionally reprogrammed conditions.Relative protein quantification and accessible biology in lung tumor proteomes from four LC-MS/MS discovery platforms.Mutational heterogeneity in non-serous ovarian cancers.Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.Increased incidence of FBXW7 and POLE proofreading domain mutations in young adult colorectal cancers.Discordance of Somatic Mutations Between Asian and Caucasian Patient Populations with Gastric Cancer.TGFβ1 overexpression is associated with improved survival and low tumor cell proliferation in patients with early-stage pancreatic ductal adenocarcinoma.Genetic Investigation of Uterine Carcinosarcoma: Case Report and Cohort Analysis.Brief Report: Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer Patients.Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer.Proliferating human cells hypomorphic for origin recognition complex 2 and pre-replicative complex formation have a defect in p53 activation and Cdk2 kinase activation.Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinomaEvaluating somatic tumor mutation detection without matched normal samples.ETV6 and signaling gene mutations are associated with secondary transformation of myelodysplastic syndromes to chronic myelomonocytic leukemia.The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation.Genomic analysis of a case of agminated Spitz nevi and congenital-pattern nevi arising in extensive nevus spilus.Tumor exome sequencing and copy number alterations reveal potential predictors of intrinsic resistance to multi-targeted tyrosine kinase inhibitors.Germline Tissues for Optimal Somatic Variant Detection in Myelodysplastic Syndromes (MDS).Human Cdt1 lacking the evolutionarily conserved region that interacts with MCM2-7 is capable of inducing re-replication.Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine.Neurofibromin level directs RAS pathway signaling and mediates sensitivity to targeted agents in malignant peripheral nerve sheath tumors.PTPN11 plays oncogenic roles and is a therapeutic target for BRAF wild-type melanomasGenome-scale analysis identifies SERPINE1 and SPARC as diagnostic and prognostic biomarkers in gastric cancer
P50
Q28397328-C756DA7F-8202-42E8-9968-AA069B19C883Q30621114-5464BD01-A984-4166-A826-972018320786Q34997502-1B787002-583E-4172-9A3D-2E0A3B37CF8AQ35077627-779E2860-8464-497D-A302-5131D1B0B7A0Q35606544-C65A5E8D-7648-4B66-909C-5B4071BAC965Q35801066-0A322597-B73C-4604-8FFE-02308B75C51CQ36037070-033A2288-FCED-4E3A-B25C-481F031EE823Q36340886-6FFB6229-3360-4DCA-B0E2-46BA2231CF10Q36551120-005A3861-B9A2-4DD0-88F3-72FD249F5BF2Q36551145-BF3507F8-651A-4067-9531-9B7A68AE17A1Q36563149-1050FF80-BD34-4DAF-8525-50F98AC4D346Q36814030-A4706D03-D636-4F26-9D54-02FAF229537DQ36889782-4ADA48CA-B4C0-4021-9FCD-5EDF7259670BQ36905613-869E1D2D-EBC5-4FFA-9356-FDE385924C26Q37017721-9FC2E9DD-17BF-4306-BD23-0684F47B9DC8Q37252201-51FB4B99-7949-4084-BCA4-0308A1327172Q37269164-BB23F910-8745-4009-ACCA-F0BF262653E8Q37706884-65B0486F-5B69-4316-A15D-5423E229E20FQ38380859-4332EA8E-5CDA-43E8-BA6C-628B0DBA2B3AQ38602953-9AE66AE7-3793-4A1B-930E-719022886D6DQ38759643-DFCB16E1-51AB-481B-9DCB-E021848EA630Q38860405-25852130-3224-4645-911C-A6C8C27180DFQ39048329-9F225A92-EF92-48C0-AEE2-CDEF54592E5FQ39147303-012622FF-9386-43E7-B4EF-B890CB788722Q39892976-1F99624D-ECEA-4EB0-B11C-8A79209C4992Q40040415-9BE007E7-1C9D-404B-88C1-2A33DF3FB13EQ40048246-29726B77-784E-4329-A32B-5AE73A016A6DQ40331152-2B44DABD-6E12-421C-BF92-6F8CF2A05F72Q40337668-F4D600A6-9F1E-4605-BDEC-6B7A0998F3A3Q41613384-FD709639-6E9A-48AC-92F4-26901D02EEE1Q42643023-C4A9134C-5E90-4546-B3A5-7C051734CADAQ47123485-E30B3BFD-209B-4E1F-9FE0-0790E543F078Q48169062-3E492F5B-72F1-4783-8AAE-9E1686FACA9EQ49184931-3493B170-2B16-4F9F-BF46-20A429E0C369Q52584783-58A48B03-7A2C-40BC-81B1-0B6C08260374Q53506242-F9BF87FF-D131-4F21-A5FE-F5153E96ECB2Q55155133-0C11F004-ED16-4E97-BA4E-B7E9DB05AD8EQ55282871-8DB738A7-371B-40B8-84D1-BF8E8F680285Q57793312-8F32914E-28EF-457C-A12D-84128479BFD9Q58565340-5E33071C-2B61-46F5-B9B7-A7407D468F25
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jamie K Teer
@en
Jamie K Teer
@nl
type
label
Jamie K Teer
@en
Jamie K Teer
@nl
prefLabel
Jamie K Teer
@en
Jamie K Teer
@nl
P31
P496
0000-0003-4513-0282